BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGEN INVESTMENT MANAGEMENT, LP | 153,474 | $1,086,596 | 0.20% |
| GW&K Investment Management, LLC | 2,570,863 | $18,201 | 0.18% |
| DOLIVER ADVISORS, LP | 81,000 | $573,480 | 0.17% |
| SEGALL BRYANT & HAMILL, LLC | 2,017,986 | $14,287,341 | 0.16% |
| Virtus ETF Advisers LLC | 38,321 | $271,313 | 0.16% |
| ELCO Management Co., LLC | 31,811 | $225,222 | 0.16% |
| Quantamental Technologies LLC | 24,160 | $171,053 | 0.16% |
| Empire Financial Management Company, LLC | 47,500 | $336,300 | 0.15% |
| Birchview Capital, LP | 20,000 | $141,600 | 0.12% |
| BENDER ROBERT & ASSOCIATES | 56,600 | $400,728 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 191,527 | $1,356 | 0.12% |
| Jump Financial, LLC | 404,913 | $2,866,784 | 0.11% |
| Trexquant Investment LP | 592,612 | $4,195,693 | 0.10% |
| Nan Fung Group Holdings Ltd | 17,847 | $126,357 | 0.10% |
| PERSONAL CFO SOLUTIONS, LLC | 66,756 | $472,632 | 0.09% |
| Bridgefront Capital, LLC | 16,323 | $115,567 | 0.08% |
| TCWP LLC | 13,500 | $95,580 | 0.07% |
| ALGERT GLOBAL LLC | 207,095 | $1,466 | 0.07% |
| Bayesian Capital Management, LP | 78,700 | $557,196 | 0.06% |
| AXQ CAPITAL, LP | 23,134 | $163,789 | 0.06% |
External links
This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.